User profiles for Eduardo Aluicio-Sarduy

Eduardo Aluicio Sarduy

University of Wisconsin-Madison
Verified email at wisc.edu
Cited by 1175

Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade

…, A Erbe, IR Marsh, I Arthur, E Aluicio-Sarduy… - Science translational …, 2021 - science.org
Molecular and cellular effects of radiotherapy on tumor microenvironment (TME) can help
prime and propagate antitumor immunity. We hypothesized that delivering radiation to all …

Fullerene-free organic solar cells with an efficiency of 3.7% based on a low-cost geometrically planar perylene diimide monomer

R Singh, E Aluicio-Sarduy, Z Kan, T Ye… - Journal of Materials …, 2014 - pubs.rsc.org
The aggregate-induced limitation for high power-conversion efficiencies (PCEs) of perylene-diimide
(PDI):polymer solar cells can be circumvented when two simple rules are respected; …

[HTML][HTML] Temporal analysis of type 1 interferon activation in tumor cells following external beam radiotherapy or targeted radionuclide therapy

…, RN Sriramaneni, JW Engle, E Aluicio-Sarduy… - Theranostics, 2021 - ncbi.nlm.nih.gov
Rationale: Clinical interest in combining targeted radionuclide therapies (TRT) with
immunotherapies is growing. External beam radiation therapy (EBRT) activates a type 1 interferon (…

Py-macrodipa: a Janus chelator capable of binding medicinally relevant rare-earth radiometals of disparate sizes

A Hu, E Aluicio-Sarduy, V Brown… - Journal of the …, 2021 - ACS Publications
Nuclear medicine leverages different types of radiometals for disease diagnosis and
treatment, but these applications usually require them to be stably chelated. Given the often-…

Ultrasmall porous silica nanoparticles with enhanced pharmacokinetics for cancer theranostics

…, ZT Rosenkrans, D Jiang, T Sun, E Aluicio-Sarduy… - Nano …, 2021 - ACS Publications
Theranostic nanoparticles hold the potential to greatly improve cancer management by
providing personalized medicine. Although many theranostic nanoconstructs have been …

Amplification of Cerenkov luminescence using semiconducting polymers for cancer theranostics

…, JC Hsu, E AluicioSarduy… - Advanced Functional …, 2023 - Wiley Online Library
The therapeutic efficacy of photodynamic therapy is limited by the ability of light to penetrate
tissues. Due to this limitation, Cerenkov luminescence (CL) from radionuclides has recently …

Establishing radiolanthanum chemistry for targeted nuclear medicine applications

E AluicioSarduy, NA Thiele, KE Martin… - … A European Journal, 2020 - Wiley Online Library
We report the first targeted nuclear medicine application of the lanthanum radionuclides 132/135
La. These isotopes represent a matched pair for diagnosis via the positron emissions of …

PET radiometals for antibody labeling

E AluicioSarduy, PA Ellison… - Journal of Labelled …, 2018 - Wiley Online Library
Recent advances in molecular characterization of tumors have made possible the emergence
of new types of cancer therapies where traditional cytotoxic drugs and nonspecific …

[HTML][HTML] 90Y-NM600 targeted radionuclide therapy induces immunologic memory in syngeneic models of T-cell Non-Hodgkin's Lymphoma

…, KL Walker, JJ Grudzinski, E Aluicio-Sarduy… - Communications …, 2019 - nature.com
Finding improved therapeutic strategies against T-cell Non-Hodgkin’s Lymphoma (NHL)
remains an unmet clinical need. We implemented a theranostic approach employing a tumor-…

[HTML][HTML] Cyclotron production of 43Sc and 44gSc from enriched 42CaO, 43CaO, and 44CaO targets

KV Becker, E Aluicio-Sarduy, T Bradshaw… - Frontiers in …, 2023 - frontiersin.org
43Sc and 44gSc are both positron-emitting radioisotopes of scandium with suitable half-lives
and favorable positron energies for clinical positron emission tomography (PET) imaging. …